Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
CET Cell Clarifies APAAR ID Issue, Says No Student Will Be Barred From MHT CET Registration Due To Name Errors
Navi Mumbai Professionals Run Themed Half Marathon At Tata Mumbai Marathon 2026 To Spread Social Awareness
Rashtriya Sevika Samiti Organizes Makar Sankranti Saghosh Sanchalan In Panvel To Promote Nation First
Top 10 Educated Newly Elected BMC Corporators In Mumbai Include Doctors, Lawyers, Business Leaders
(With inputs from PTI)
